An interventional study of ENHANCe app and Teaching and training in Hypertension,Essential, sponsored by SingHealth Polyclinics. Enrolling by invitation at 1 site in Singapore. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-02-10.
Sponsored by SingHealth Polyclinics · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study is testing a new app called ENHANCe, which is designed to help family doctors manage patients with high blood pressure using readings taken at home.
The researchers want to find out if the app is easy to use in everyday clinic settings, whether doctors find it helpful and are willing to use it, and if it helps improve care. The study will involve 16 doctors and 100 patients with high blood pressure, split into two groups at two clinics. One group will use the ENHANCe app, which can read blood pressure data from different sources-including handwritten notes-and give doctors advice based on that information. The other group will receive regular care without the app. Over six months, researchers will collect feedback from doctors through surveys and group discussions at the end of the study. They'll also track how many people complete the study, how long clinic visits take, whether doctors follow the app's advice, and how well patients' blood pressure is controlled. The goal is to see if the app can help doctors make faster, better decisions and improve health outcomes for people managing their blood pressure at home.
481 studies on the registry are indexed under Essential Hypertension; 75 are open to participants now.
This study's planned enrollment of 116 is below the median of 144 across 408 interventional studies indexed under Essential Hypertension.
Browse Essential Hypertension studies →SingHealth Polyclinics is the lead sponsor of 23 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
For primary care physicians:
For patients:
Exclusion Criteria for patients:
All patients will have access to online educational resources throughout the study. After recruitment, they will receive a nurse-led education on HBP monitoring. The research team will train all primary care physicians (PCPs) on managing patients with hypertension using HBP records. The PCPs in the intervention group will be briefed on how the ENHANCe app works, and its recommendations. The ENHANCe app will be installed on designated mobile phones, and research staff will analyse HBP records during visits, documenting the output for PCPs to use. Based on the app's recommendations, patients will consult with intervention group PCPs 2-3 times throughout the study, with the last follow-up at 6 months. PCPs will complete a consult checklist after each visit. FGDs will be conducted with PCPs at the end of the study. The interviews will be recorded and transcribed for analysis.
Device: ENHANCe app · Other: Teaching and training
All patients will have access to online educational resources throughout the study. After recruitment, they will receive a nurse-led education on HBP monitoring. The research team will train all primary care physicians (PCPs) on managing patients with hypertension using HBP records. Control group PCPs will manage patients using HBP records at their discretion, with a final follow-up scheduled at 6 months. PCPs will complete a consult checklist after each visit. Research staff will use the ENHANCe app to analyse BP diaries and document outcomes, but control group PCPs will not have access to the app or its results.
Other: Teaching and training · Other: Usual care
ENHANCe app is a prototype; it is a smartphone based clinical decision support (CDS) tool to manage patients with hypertension using their home blood pressure. The app will scan patients' home BP records from paper or mobile phone, and provide a recommendation to the doctor on how to manage their blood pressure. The patient will not need to use the device during the study period. However, the recommendation from the ENHANCe app will be available to the doctor to manage your blood pressure during the study period if the patient is in the intervention group.
All patients will have access to online educational resources throughout the study. After recruitment, they will receive a nurse-led education on HBP monitoring. The research team will train all primary care physicians (PCPs) on managing patients with hypertension using HBP records.
Physicians manage patients using HBP records at their discretion
Response rate of participants
Participants agreeable to participate in the study
Time frame: 6 months
Agreement with the CDSS recommendation among PCPs
Proportion of PCPs who agree with the CDSS recommendation in the two groups
Time frame: 6 months
Withdrawal rate
Proportion of participants who withdrew
Time frame: 6 months
Study completion rate
Proportion of participants who completed the intervention
Time frame: 6 months
Adverse event rates
Proportion of adverse events reported in the two groups
Time frame: 6 months
Consult duration
Consult time in the groups
Time frame: 6 months
Ease of home blood pressure record assessment among PCPS
Ease of home blood pressure record assessment among PCPS in the two arms
Time frame: 6 months
Proportion of CDSS recommendation followed by the PCPS
Proportion of ENHANCe recommendations followed by the PCPs among the two groups
Time frame: 6 months
Blood pressure control status
Blood pressure control status among patients in the two groups
Time frame: 6 months
Plan to share: No — IPD will not be shared
No publications or documents are linked to this record.
Started Oct 2025 (actual). Primary completion is estimated for Oct 2026, 12 months after the start.
Of 70 non-industry interventional studies with no phase under Essential Hypertension, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 47. This study's planned 12 months is below that.
Counting every sponsor, half of 80 studies reached it within 20 months; a quarter within 8 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
SingHealth Polyclinics